Island Pharmaceuticals Ltd (ILA) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.237x

Based on the latest financial reports, Island Pharmaceuticals Ltd (ILA) has a cash flow conversion efficiency ratio of -0.237x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.69 Million ≈ $-1.20 Million USD) by net assets (AU$7.16 Million ≈ $5.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Island Pharmaceuticals Ltd market capitalisation for the company's overall valuation and market capitalisation.

Island Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Island Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Island Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Island Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. See ILA debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Fortress Biotech Inc NASDAQ:FBIO	-0.202x
Azaria Rental SOCIMI S.A. MC:YAZR	-0.025x
G J Steel Public Company Limited BK:GJS	0.051x
Life Settlement Assets PLC LSE:LSAA	0.123x
Vera Bradley Inc NASDAQ:VRA	-0.042x
VIVANI MED.INC. NEW O.N. F:U5P	-0.427x
CAIRO MEZZ PLC EO-10 F:6H3	N/A
Thai Rung Union Car Public Company Limited BK:TRU	0.013x

Annual Cash Flow Conversion Efficiency for Island Pharmaceuticals Ltd (2019–2024)

The table below shows the annual cash flow conversion efficiency of Island Pharmaceuticals Ltd from 2019 to 2024. View Island Pharmaceuticals Ltd (ILA) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$7.16 Million ≈ $5.06 Million	AU$-2.77 Million ≈ $-1.96 Million	-0.387x	+81.44%
2023-12-31	AU$1.52 Million ≈ $1.07 Million	AU$-3.16 Million ≈ $-2.24 Million	-2.084x	-37.34%
2022-12-31	AU$1.79 Million ≈ $1.26 Million	AU$-2.71 Million ≈ $-1.92 Million	-1.517x	-248.92%
2021-12-31	AU$4.32 Million ≈ $3.06 Million	AU$-1.88 Million ≈ $-1.33 Million	-0.435x	-196.57%
2020-12-31	AU$6.40 Million ≈ $4.53 Million	AU$-938.24K ≈ $-663.86K	-0.147x	-702.06%
2019-12-31	AU$-657.00 ≈ $-464.87	AU$-16.00 ≈ $-11.32	0.024x	--

About Island Pharmaceuticals Ltd

AU:ILA Australia Biotechnology

Market Cap

$79.39 Million

AU$112.19 Million AUD

Market Cap Rank

#20203 Global

#669 in Australia

Share Price

AU$0.42

Change (1 day)

-0.71%

52-Week Range

AU$0.32 - AU$0.57

All Time High

AU$0.57